1-6 of 6
Jonathan E Benjamin
Close
Sort by
Journal Articles

A CD19/CD20-Directed Bispecific CAR-T Cell Therapy in Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)

Sarah M. Larson, Yvonne Y Chen, Jim Johnston, Sylvain Roy, Pinakin Patel, Jonathan E Benjamin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6892.
https://doi.org/10.1182/blood-2023-187614
Published: 2023
Journal Articles

Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

Clinical Trials & Observations
Nicola Gökbuget, Hervé Dombret, Massimiliano Bonifacio, Albrecht Reichle, Carlos Graux, Christoph Faul, Helmut Diedrich, Max S. Topp, Monika Brüggemann, Heinz-August Horst, Violaine Havelange, Julia Stieglmaier, Hendrik Wessels, Vincent Haddad, Jonathan E. Benjamin, Gerhard Zugmaier, Dirk Nagorsen, Ralf C. Bargou
Journal: Blood
Blood (2018) 131 (14): 1522–1531.
https://doi.org/10.1182/blood-2017-08-798322
Published: 2018
Includes: Supplemental data
Journal Articles

Assessment of Tumor Depletion Following Tandem Mobilization in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation

David B. Miklos, Aaron C. Logan, Christine E. Ryan, Kelsi Schoenrock, Maria Garcia, Mark Klinger, Katherine A Kong, Malek Faham, Rob Negrin, Jonathan E. Benjamin
Journal: Blood
Blood (2014) 124 (21): 2010.
https://doi.org/10.1182/blood.V124.21.2010.2010
Published: 2014
Journal Articles

Non-Myeloablative Allogeneic Transplantation Resulting in Clinical and Molecular Remission with Low Non-Relapse Mortality (NRM) in Patients with Advanced Stage Mycosis Fungoides (MF) and Sézary Syndrome (SS)

Wen-Kai Weng, MD PhD, Randall Armstrong, Sally Arai, MD, Laura Johnston, MD, Ginna G. Laport, MD, Robert Lowsky, MD, David B. Miklos, Judith A. Shizuru, MD PhD, Jonathan E. Benjamin, Robert S. Negrin, MD, Sunil Reddy, MD, Lynn Million, MD, Richard T. Hoppe, MD, Youn H. Kim, MD
Journal: Blood
Blood (2014) 124 (21): 2544.
https://doi.org/10.1182/blood.V124.21.2544.2544
Published: 2014
Journal Articles

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

Clinical Trials & Observations
Sally Arai, Bita Sahaf, Balasubramanian Narasimhan, George L. Chen, Carol D. Jones, Robert Lowsky, Judith A. Shizuru, Laura J. Johnston, Ginna G. Laport, Wen-Kai Weng, Jonathan E. Benjamin, Joanna Schaenman, Janice Brown, Jessica Ramirez, James L. Zehnder, Robert S. Negrin, David B. Miklos
Journal: Blood
Blood (2012) 119 (25): 6145–6154.
https://doi.org/10.1182/blood-2011-12-395970
Published: 2012
Includes: Supplemental data
Journal Articles

Long-Term Outcomes of Myeloablative Conditioning and Matched-Related Donor Hematopoietic Cell Transplantation for Patients with High-Risk and Advanced-Stage Hematolymphoid Malignancies

Jonathan E. Benjamin, MD, PhD, Ginna G. Laport, MD, Laura J. Johnston, MD, Sally Arai, MD, Wen-Kai Weng, MD, PhD, Judith A. Shizuru, MD, PhD, David B. Miklos, MD, PhD, Ruby M. Wong, PhD, Linda V. Elder, Karl G. Blume, MD, Robert S. Negrin, MD, Robert Lowsky, MD
Journal: Blood
Blood (2008) 112 (11): 4383.
https://doi.org/10.1182/blood.V112.11.4383.4383
Published: 2008